Aquestive Therapeutics Inc (AQST)
2.90
-0.01
(-0.34%)
USD |
NASDAQ |
May 31, 16:00
2.895
0.00 (0.00%)
After-Hours: 20:00
Aquestive Therapeutics Gross Profit (TTM): 31.02M for March 31, 2024
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 31.02M |
December 31, 2023 | 29.75M |
September 30, 2023 | 26.60M |
June 30, 2023 | 25.24M |
March 31, 2023 | 26.64M |
December 31, 2022 | 28.29M |
September 30, 2022 | 30.63M |
June 30, 2022 | 32.68M |
March 31, 2022 | 35.53M |
December 31, 2021 | 35.84M |
September 30, 2021 | 32.49M |
June 30, 2021 | 28.89M |
March 31, 2021 | 36.14M |
Date | Value |
---|---|
December 31, 2020 | 32.88M |
September 30, 2020 | 38.15M |
June 30, 2020 | 40.64M |
March 31, 2020 | 28.22M |
December 31, 2019 | 32.25M |
September 30, 2019 | 34.66M |
June 30, 2019 | 34.56M |
March 31, 2019 | 37.80M |
December 31, 2018 | 46.44M |
September 30, 2018 | 40.98M |
June 30, 2018 | 55.58M |
March 31, 2018 | 52.62M |
December 31, 2017 | 47.10M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
25.24M
Minimum
Jun 2023
40.64M
Maximum
Jun 2020
32.06M
Average
32.37M
Median
Gross Profit (TTM) Benchmarks
Lifecore Biomedical Inc | 27.73M |
Harrow Inc | 96.76M |
Akebia Therapeutics Inc | 121.66M |
89bio Inc | -- |
Humacyte Inc | -- |